Skip to main content
Erschienen in: Journal of Cancer Research and Clinical Oncology 11/2016

17.06.2016 | Review – Clinical Oncology

Oral antineoplastic agent interactions with medicinal plants and food: an issue to take into account

verfasst von: Roberto Collado-Borrell, Vicente Escudero-Vilaplana, Rosa Romero-Jiménez, Irene Iglesias-Peinado, Ana Herranz-Alonso, María Sanjurjo-Sáez

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 11/2016

Einloggen, um Zugang zu erhalten

Abstract

Objective

To review interactions between oral antineoplastic agents (OAAs) for the treatment of solid and hematological tumors and common food and medicinal plants.

Materials and methods

All potential interactions between OAAs, medicinal plants and food were reviewed. OAAs were considered to be drugs for oral administration that have direct antitumor activity and were approved by the European Medicines Agency in April 2015. We performed the literature search in Pubmed® considering only medicinal plants and food. In addition, available data were analyzed from each OAA in secondary data sources taken from Thomson Micromedex® and Lexi-comp®, as well as in the summary of product characteristics.

Results

Fifty-eight OAAs were analyzed. We found interactions in 60.3 % of OAAs. Those with most interactions described were: imatinib and procarbazine (4 interactions) and erlotinib, vemurafenib, pomalidomide, medroxyprogesterone and methotrexate (3 interactions).

Medicinal plants

We found 39 interactions (74.4 % important). St. John’s wort was the medicinal plant with most interactions (92.6 % were considered important). The rest were: important (ginseng–imatinib, methotrexate–cola and tobacco–erlotinib and tobacco–pomalidomide) and moderate (caffeine–vemurafenib/medroxyprogesterone, medroxyprogesterone–ruxolitinib/St. John’s wort, garlic–anagrelide and ginseng–procarbazine).

Foods

Twenty-six interactions (61.5 % important). Grapefruit had most interactions (82.4 % were considered important). The rest were: important (alcohol–procarbazine) and moderate (dairy–estramustine, methotrexate–ethanol, procarbazine–tyramine, vitamin A–tretinoin/bexarotene and grapefruit–bexarotene/etoposide/sunitinib).

Conclusion

A review of interactions of medicinal plants and food should be taken into account in the management of OAAs, since more than half have interactions with MPs and food, of which 70.3 % are considered important. The most relevant are HSJ, grapefruit, ginseng and tobacco. This review is intended to serve as a support to all healthcare professionals at the time of prescribing or dispensing OAAs.
Literatur
Zurück zum Zitat Bauters T, Lammens T, Belin P, Benoit Y, Robays H, De Moerloose B (2013) Delayed elimination of methotrexate by cola beverages in a pediatric acute lymphoblastic leukemia population. Leuk Lymph 54(5):1094–1096. doi:10.3109/10428194.2012.737918 CrossRef Bauters T, Lammens T, Belin P, Benoit Y, Robays H, De Moerloose B (2013) Delayed elimination of methotrexate by cola beverages in a pediatric acute lymphoblastic leukemia population. Leuk Lymph 54(5):1094–1096. doi:10.​3109/​10428194.​2012.​737918 CrossRef
Zurück zum Zitat Brinker F (2010) Herbal contraindications and drug interactions plus herbal adjuncts with medicines, 4th edn. Eclectic Medical Publications, Sandy, Oregon Brinker F (2010) Herbal contraindications and drug interactions plus herbal adjuncts with medicines, 4th edn. Eclectic Medical Publications, Sandy, Oregon
Zurück zum Zitat Cui Y, Shu X-O, Gao Y-T, Cai H, Tao M-H, Zheng W (2006) Association of ginseng use with survival and quality of life among breast cancer patients. Am J Epidemiol 163(7):645–653. doi:10.1093/aje/kwj087 PubMedCrossRef Cui Y, Shu X-O, Gao Y-T, Cai H, Tao M-H, Zheng W (2006) Association of ginseng use with survival and quality of life among breast cancer patients. Am J Epidemiol 163(7):645–653. doi:10.​1093/​aje/​kwj087 PubMedCrossRef
Zurück zum Zitat Curtiss FR (2006) Pharmacy benefit spending on oral chemotherapy drugs. J Manag Care Pharm JMCP 12(7):570–577PubMed Curtiss FR (2006) Pharmacy benefit spending on oral chemotherapy drugs. J Manag Care Pharm JMCP 12(7):570–577PubMed
Zurück zum Zitat Fleisher B, Unum J, Shao J, An G (2015) Ingredients in fruit juices interact with dasatinib through inhibition of BCRP: a new mechanism of beverage–drug interaction. J Pharm Sci 104(1):266–275. doi:10.1002/jps.24289 PubMedCrossRef Fleisher B, Unum J, Shao J, An G (2015) Ingredients in fruit juices interact with dasatinib through inhibition of BCRP: a new mechanism of beverage–drug interaction. J Pharm Sci 104(1):266–275. doi:10.​1002/​jps.​24289 PubMedCrossRef
Zurück zum Zitat Grossberg GT, Fox B (2008) The essential herb-drug-vitamin interaction guide: the safe way to use medications and supplements together. Potter/TenSpeed/Harmony, p 624 Grossberg GT, Fox B (2008) The essential herb-drug-vitamin interaction guide: the safe way to use medications and supplements together. Potter/TenSpeed/Harmony, p 624
Zurück zum Zitat Hao M, Ba Q, Yin J, Li J, Zhao Y, Wang H (2011) Deglycosylated ginsenosides are more potent inducers of CYP1A1, CYP1A2 and CYP3A4 expression in HepG2 cells than glycosylated ginsenosides. Drug Metab Pharmacokinet 26(2):201–205PubMedCrossRef Hao M, Ba Q, Yin J, Li J, Zhao Y, Wang H (2011) Deglycosylated ginsenosides are more potent inducers of CYP1A1, CYP1A2 and CYP3A4 expression in HepG2 cells than glycosylated ginsenosides. Drug Metab Pharmacokinet 26(2):201–205PubMedCrossRef
Zurück zum Zitat Johnston CS, Gaas CA (2006) Vinegar: medicinal uses and antiglycemic effect. MedGenMed: Medscape Gen Med 8(2):61 Johnston CS, Gaas CA (2006) Vinegar: medicinal uses and antiglycemic effect. MedGenMed: Medscape Gen Med 8(2):61
Zurück zum Zitat Lee Y, Jin Y, Lim W, Ji S, Choi S, Jang S, Lee S (2003) A ginsenoside-Rh1, a component of ginseng saponin, activates estrogen receptor in human breast carcinoma MCF-7 cells. J Steroid Biochem Mol Biol 84(4):463–468PubMedCrossRef Lee Y, Jin Y, Lim W, Ji S, Choi S, Jang S, Lee S (2003) A ginsenoside-Rh1, a component of ginseng saponin, activates estrogen receptor in human breast carcinoma MCF-7 cells. J Steroid Biochem Mol Biol 84(4):463–468PubMedCrossRef
Zurück zum Zitat Liu G, Franssen E, Fitch MI, Warner E (1997) Patient preferences for oral versus intravenous palliative chemotherapy. J Clin Oncol Off J Am Soc Clin Oncol 15(1):110–115 Liu G, Franssen E, Fitch MI, Warner E (1997) Patient preferences for oral versus intravenous palliative chemotherapy. J Clin Oncol Off J Am Soc Clin Oncol 15(1):110–115
Zurück zum Zitat Molassiotis A, Fernadez-Ortega P, Pud D, Ozden G, Scott JA, Panteli V, Margulies A et al (2005) Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol Off J Eur Soc Med Oncol ESMO 16(4):655–663. doi:10.1093/annonc/mdi110 CrossRef Molassiotis A, Fernadez-Ortega P, Pud D, Ozden G, Scott JA, Panteli V, Margulies A et al (2005) Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol Off J Eur Soc Med Oncol ESMO 16(4):655–663. doi:10.​1093/​annonc/​mdi110 CrossRef
Zurück zum Zitat Nowack R (2008) Review article: cytochrome P450 enzyme, and transport protein mediated herb-drug interactions in renal transplant patients: grapefruit juice, St. John’s Wort and Beyond! Nephrology (Carlton, Vic) 13(4):337–347. doi:10.1111/j.1440-1797.2008.00940.x CrossRef Nowack R (2008) Review article: cytochrome P450 enzyme, and transport protein mediated herb-drug interactions in renal transplant patients: grapefruit juice, St. John’s Wort and Beyond! Nephrology (Carlton, Vic) 13(4):337–347. doi:10.​1111/​j.​1440-1797.​2008.​00940.​x CrossRef
Zurück zum Zitat Robey RW, Shukla S, Finley EM, Oldham RK, Barnett D, Ambudkar SV, Fojo T, Bates SE (2008) Inhibition of P-glycoprotein (ABCB1)- and multidrug resistance-associated protein 1 (ABCC1)-mediated transport by the orally administered inhibitor, CBT-1((R)). Biochem Pharmacol 75(6):1302–1312. doi:10.1016/j.bcp.2007.12.001 PubMedCrossRef Robey RW, Shukla S, Finley EM, Oldham RK, Barnett D, Ambudkar SV, Fojo T, Bates SE (2008) Inhibition of P-glycoprotein (ABCB1)- and multidrug resistance-associated protein 1 (ABCC1)-mediated transport by the orally administered inhibitor, CBT-1((R)). Biochem Pharmacol 75(6):1302–1312. doi:10.​1016/​j.​bcp.​2007.​12.​001 PubMedCrossRef
Zurück zum Zitat Sørensen JM (2002) Herb-drug, food-drug, nutrient-drug, and drug–drug interactions: mechanisms involved and their medical implications. J Altern Complement Med (New York, NY) 8(3):293–308. doi:10.1089/10755530260127989 CrossRef Sørensen JM (2002) Herb-drug, food-drug, nutrient-drug, and drug–drug interactions: mechanisms involved and their medical implications. J Altern Complement Med (New York, NY) 8(3):293–308. doi:10.​1089/​1075553026012798​9 CrossRef
Zurück zum Zitat Strandell J, Neil A, Carlin G (2004) An approach to the in vitro evaluation of potential for cytochrome P450 enzyme inhibition from herbals and other natural remedies. Phytomed Int J Phytother Phytopharmacol 11(2–3):98–104. doi:10.1078/0944-7113-00379 CrossRef Strandell J, Neil A, Carlin G (2004) An approach to the in vitro evaluation of potential for cytochrome P450 enzyme inhibition from herbals and other natural remedies. Phytomed Int J Phytother Phytopharmacol 11(2–3):98–104. doi:10.​1078/​0944-7113-00379 CrossRef
Zurück zum Zitat van Erp NP, Baker SD, Zandvliet AS, Ploeger BA, den Hollander M, Chen Z, den Hartigh J, König-Quartel JMC, Guchelaar HJ, Gelderblom H (2011) Marginal increase of sunitinib exposure by grapefruit juice. Cancer Chemother Pharmacol 67(3):695–703. doi:10.1007/s00280-010-1367-0 PubMedCrossRef van Erp NP, Baker SD, Zandvliet AS, Ploeger BA, den Hollander M, Chen Z, den Hartigh J, König-Quartel JMC, Guchelaar HJ, Gelderblom H (2011) Marginal increase of sunitinib exposure by grapefruit juice. Cancer Chemother Pharmacol 67(3):695–703. doi:10.​1007/​s00280-010-1367-0 PubMedCrossRef
Zurück zum Zitat Wanwimolruk S, Wong K, Wanwimolruk P (2009) Variable inhibitory effect of different brands of commercial herbal supplements on human cytochrome P-450 CYP3A4. Drug Metab Drug Interact 24(1):17–35CrossRef Wanwimolruk S, Wong K, Wanwimolruk P (2009) Variable inhibitory effect of different brands of commercial herbal supplements on human cytochrome P-450 CYP3A4. Drug Metab Drug Interact 24(1):17–35CrossRef
Zurück zum Zitat Weingart SN, Brown E, Bach PB, Eng K, Johnson SA, Kuzel TM, Langbaum TS et al (2008) NCCN task force report: oral chemotherapy. J Natl Compr Cancer Netw JNCCN 6(Suppl 3):S1–S14PubMed Weingart SN, Brown E, Bach PB, Eng K, Johnson SA, Kuzel TM, Langbaum TS et al (2008) NCCN task force report: oral chemotherapy. J Natl Compr Cancer Netw JNCCN 6(Suppl 3):S1–S14PubMed
Metadaten
Titel
Oral antineoplastic agent interactions with medicinal plants and food: an issue to take into account
verfasst von
Roberto Collado-Borrell
Vicente Escudero-Vilaplana
Rosa Romero-Jiménez
Irene Iglesias-Peinado
Ana Herranz-Alonso
María Sanjurjo-Sáez
Publikationsdatum
17.06.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 11/2016
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-016-2190-8

Weitere Artikel der Ausgabe 11/2016

Journal of Cancer Research and Clinical Oncology 11/2016 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.